Five months after COVID crisis, drug sales report growth of 4.5 percent at Rs 13170 crore: AIOCD-AWACS Report Farhat Nasim7 Oct 2020 5:41 PM ISTNew Delhi: The Indian Pharma Market for the first time has come back very strongly after 5 months of the COVID crisis and registered a growth of 4.5%...
Glenmark gets USFDA approval for Dimethyl Fumarate Delayed-Release Capsules Ruchika Sharma7 Oct 2020 3:13 PM ISTMumbai: Glenmark Pharmaceuticals Inc., USA today announced that the company has been granted final approval by the United States Food & Drug...
Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major slumps: AIOCD-AWACS report Farhat Nasim12 Sept 2020 1:08 PM ISTNew Delhi: Amid the ongoing COVID-19 crisis, the month of August remained unfavorable for the Indian pharmaceutical market as data from market...
NPPA fixes retail price of Glenmark Vildagliptin, Metformin combo drug at Rs 6.17 per tablet Farhat Nasim1 Sept 2020 2:26 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has recently fixed the price of popular combination formulation, Vildagliptin +...
Dipankar Bhattacharjee appointed as new Independent Non-Executive Director of Glenmark Ruchika Sharma18 Aug 2020 12:14 PM ISTMumbai: Glenmark Pharmaceuticals has announced the appointment of Mr. Dipankar Bhattacharjee as Independent Non-Executive Director on the...
Glenmark net profit leaps over two fold to Rs 254 crore in Q1 Ruchika Sharma17 Aug 2020 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals on Friday posted an over two-fold increase in consolidated net profit at Rs 254.04 crore for the quarter...
Govt incentives for domestic API to cut supply risk for Indian drug makers: Fitch Ruchika Sharma11 Aug 2020 12:00 PM ISTThe production-linked incentive scheme -- which accounts for Rs 90 crore of planned outlay -- offers an incentive of up to 20 per cent of sales for...
Glenmark to introduce stronger version of FabiFlu in India for COVID treatment Ruchika Sharma7 Aug 2020 1:19 PM ISTGlenmark is the first company in India to have received regulator Drug Controller General of India's approval for the 400 mg dosage form, the...
Cipla to soon unveil COVID drug Ciplenza for Rs 68 MD Bureau25 July 2020 11:00 AM ISTCipla said it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.
Glenmark Favipiravir phase 3 Trial in COVID Patients show promise Ruchika Sharma23 July 2020 10:30 AM ISTMumbai: Glenmark Pharmaceuticals Ltd. has announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients, conducted...
Overpricing allegations on Fabiflu careless, unsubstantiated: Glenmark to DCGI Ruchika Sharma22 July 2020 4:45 PM ISTNew Delhi: Quashing allegations of 'false claims' and overpricing of COVID drug Favipiravir, drug major Glenmark Pharmaceuticals Ltd has recently...
DCGI slams Glenmark over misleading claims, price of COVID drug FabiFlu Ruchika Sharma20 July 2020 4:13 PM ISTMaking false claims without substantial clinical evidence in media is misleading to the patients and clinicians in such a global pandemic situation....
